NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
The Goldman Sachs Group, Inc. (NYSE: GS)
Class Period: February 28, 2014 - December 17, 2018
Lead Plaintiff Deadline: February 19, 2019
Join the action: https://www.zlk.com/pslra-1/the-goldman-sachs-group-inc-loss-form?wire=3
Allegations: The Goldman Sachs Group, Inc. made materially false and/or misleading statements and/or failed to disclose that:
(1) Goldman Sachs participated in a fraud and money-laundering scheme in collusion with 1Malaysia Development Bhd., a Malaysian
state-owned investment fund; (2) the foregoing conduct, when revealed, would foreseeably subject Goldman Sachs to heightened
regulatory investigations and enforcement; and (3) as a result, Goldman Sachs’s public statements were materially false and
misleading at all relevant times.
To learn more about the The Goldman Sachs Group, Inc. class action contact jlevi@levikorsinsky.com.
Marriott International, Inc. (NASDAQGS: MAR)
Class Period: November 9, 2016 - November 29, 2018
Lead Plaintiff Deadline: January 30, 2019
Join the action: https://www.zlk.com/pslra-1/marriott-international-inc-loss-form?wire=3
Allegations: During the class period, Marriott International, Inc. made materially false and/or misleading statements and/or
failed to disclose that: (1) Marriott’s and Starwood’s systems storing their customers’ personal data were not secure; (2) there
had been unauthorized access on Starwood’s network since 2014; (3) consequently, the personal data of approximately 500 million
Starwood guests and the sensitive personal information of approximately 327 million of those guests may have been exposed to
unauthorized parties; and (4) as a result, Marriott’s public statements were materially false and/or misleading at all relevant
times.
To learn more about the Marriott International, Inc. class action contact jlevi@levikorsinsky.com.
YRC Worldwide Inc. (NASDAQGS: YRCW)
Class Period: March 10, 2014 - December 14, 2018
Lead Plaintiff Deadline: March 4, 2019
Join the action: https://www.zlk.com/pslra-1/yrc-worldwide-inc-loss-form?wire=3
Allegations: YRC Worldwide Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) from 2005
to at least 2013, YRC's units systematically overcharged the federal government for freight carrier services; (2) this alleged
misconduct caused the Department of Defense to overpay by millions of dollars for shipments that were lighter, and thus cheaper,
than the weights for which the government was charged; (3) consequently, this alleged misconduct would subject YRC to enhanced
government scrutiny and liabilities, including potentially owing treble damages under the False Claims Act; and (4) as a result,
the Company’s public statements were materially false and misleading at all relevant times.
To learn more about the YRC Worldwide Inc. class action contact jlevi@levikorsinsky.com.
Allergan plc (NYSE: AGN)
Class Period: May 9, 2017 - December 19, 2018
Lead Plaintiff Deadline: February 19, 2019
Join the action: https://www.zlk.com/pslra-1/allergan-plc-loss-form?wire=3
During the Class Period, and unbeknownst to investors, Allergan misled investors regarding various “pharma and device approvals”
and concealed the fact that the Company’s CE Mark for its textured breast implants and tissue expanders was expiring in
Europe. On December 19, 2018, the Company announced that, following a compulsory recall request from Agence Nationale de
Sécurité du Médicament (“ANSM”), the French regulatory authority, the Company had suspended the sale of these products and that it
was withdrawing all remaining supplies from European markets. The suspension of sales stemmed directly from the expiration of the
company's CE Mark for these products, and the stock price fell drastically following the news.
To learn more about the Allergan plc class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
